Nestlé Health Science and Moog announce North American exclusive distribution agreement for EnteraLite® Infinity® Pump

Nestlé Health Science and Moog announce North American exclusive distribution 
agreement for EnteraLite® Infinity® Pump 
New agreement expands access to state-of-the-art enteral delivery systems for 
hospital and home care patients 
FLORHAM PARK, NJ, Feb. 22, 2013 /CNW/ - Nestlé Health Science and Moog Inc. 
announced today that effective immediately Nestlé Health Science will become 
the exclusive distributor in the U.S. and Canada for Moog's EnteraLite(®) 
Infinity(®) Pump, including compatible administration sets and accessories. 
The EnteraLite(®) Infinity(®) Pump is regarded as one of the leading enteral 
(tube feeding) delivery systems in the North American market. The agreement 
between Nestlé Health Science and Moog expands availability of a 
state-of-the-art enteral delivery system that can be used across the full 
continuum of care - for adult and pediatric patients in the hospital and at 
home. Working together, both companies are now well positioned to meet the 
needs of hospital, home care and other alternate site customers. 
"We are very pleased to enter into this agreement with Moog so that we can 
offer an innovative product like the EnteraLite(®) Infinity(®) Pump through 
the strength of our established Sales Force in the U.S. and Canada," said 
David Yates, North American Region Head for the HealthCare Nutrition business 
within Nestlé Health Science. "We see this agreement as an important part of 
our plan to fulfill the Nestlé Health Science mission of Nourishing Personal 
Health by delivering innovative, patient centric nutritional solutions. With 
this agreement in place, Nestlé Health Science offers the most comprehensive 
array of science-based nutritional formulas, enteral delivery systems and 
feeding tubes available in North America." 
"The relationship between Nestlé Health Science and Moog Medical Devices 
Group is an extremely important combination of the best that can be offered in 
the marketplace," said Martin Berardi, President, Moog Medical Devices Group. 
"Our relationship has developed into one where trust and cooperation is the 
main ingredient which will provide excellent outcomes today and also into the 
future." 
The terms of this agreement are not being disclosed. 
About Nestlé Health Science
Nestlé Health Science was formed in January 2011 to spearhead the development 
of science-based personalized nutritional solutions. Building on its core 
HealthCare Nutrition business, the company has ambitions to address chronic 
conditions in the area of Gastrointestinal Health, Metabolic Health and Brain 
Health. Nestlé Health Science offers nutritional solutions for people with 
specific dietary needs related to illnesses, disease states or the special 
challenges of different life stages. Nestlé Health Science is a wholly owned 
subsidiary of Nestlé S.A., with worldwide headquarters in Lutry, Switzerland. 
Additional information can be found at www.nestlehealthscience.us. 
About Moog Medical Devices
Moog Medical Devices, part of Moog Inc. (NYSE: MOG.A and MOG.B), supports 
intravenous (IV) therapy and enteral nutrition delivery with a suite of pumps, 
fluid delivery systems and components. Moog Inc. is a worldwide designer, 
manufacturer, and integrator of precision control components and systems. 
Additional information about the Company can be found at www.moog.com.  
Contacts: 
In the United States: Mary Wade Nestlé Health Science Phone: 612-384-8484 
mary.wade@us.nestle.com 
In Canada: Selena Fiacco Nestlé Canada Phone: 416-218-2814 
selena.fiacco@ca.nestle.com 
SOURCE: Nestle Canada Inc. 
To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/February2013/22/c7676.html 
CO: Nestle Canada Inc.
ST: New Jersey
NI: FBR FOD HEA HEA ORDER NP  
-0- Feb/22/2013 14:00 GMT